PROK
PROK
NASDAQ · Biotechnology

Prokidney Corp

$1.83
+0.04 (+2.23%)
As of Mar 25, 10:04 PM ET ·
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 10 67%
Hold 4 27%
Sell 1 7%
Price Target
Analyst Price Target +983.1% upside
Low Target $13.43
Average Target $19.82
High Target $25.07
Current Price $1.83
Current
$1.83
Target
$19.82
$13.43 $19.82 avg $25.07
Scenario Analysis
Bear Case
$13.43
633.9%
Low target
Base Case
$19.82
+983.1%
Avg target
Bull Case
$25.07
+1,269.9%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$7.13
-74.3% from high
52-Week Low
$0.46
+297.6% from low
Target vs 52W High
$19.82
+178.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%